Home › NDC Lookup › RxCUI directory › RxCUI 2179647

Triprolidine hydrochloride 0.625 MG/ML Oral Solution [Pediaclear Childrens] — RxCUI 2179647

Name: Triprolidine hydrochloride 0.625 MG/ML Oral Solution [Pediaclear Childrens] (RxCUI 2179647)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2179647 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2179647

Official nameTriprolidine hydrochloride 0.625 MG/ML Oral Solution [Pediaclear Childrens]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asPediaclear Childrens 0.625 MG/ML Oral Solution; Pediaclear Childrens PD 1.25 MG in 2 mL Oral Solution

FDA products mapped1

Package NDCs mapped1

Reported Medicaid activity (SDUD)15,849 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Triprolidine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Triprolidine helps relieve the common, uncomfortable symptoms of hay fever and other upper respiratory allergies — things like a runny nose, sneezing, itchy or watery eyes, and itc...
Yes, drowsiness is a real possibility with triprolidine, and it's something to take seriously. Avoid driving, operating machinery, or doing anything that needs sharp focus until yo...
For children under 6 years old, you should check with a doctor before giving any triprolidine product. The labels for these products don't include dosing for that age group without...
Yes — if you have emphysema, chronic bronchitis, glaucoma, or trouble urinating due to an enlarged prostate, you should not take triprolidine without talking to a doctor first. The...

📖 Read our full Triprolidine guide →

🕸️ Concept Web — How Triprolidine hydrochloride 0.625 MG/ML Oral Solu... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Triprolidine hydrochloride 0.625 MG/ML Oral Solution [Pediaclear Childrens] RxCUI 2179647 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Triprolidine 10849 IN
- Triprolidine hydrochloride 71534 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Pediaclear Childrens 2179642 BN
Dose forms 13

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Triprolidine Oral Solution 376317 SCDF
- Triprolidine hydrochloride Oral Solution 2647555 SCDFP
- Triprolidine Oral Liquid Product 1159349 SCDG
- Triprolidine Oral Product 1159350 SCDG
- Triprolidine hydrochloride Oral Liquid Product 2659962 SCDGP
- Triprolidine hydrochloride Oral Product 2661554 SCDGP
- Triprolidine Oral Solution [Pediaclear Childrens] 2179644 SBDF
- Triprolidine hydrochloride Oral Solution [Pediaclear Childrens] 2658680 SBDFP
- +5 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Triprolidine hydrochloride 0.625 MG/ML Oral Solution 1428927 SCD
- Triprolidine hydrochloride 0.625 MG/ML 1428926 SCDC
- Triprolidine hydrochloride 0.625 MG/ML [Pediaclear Childrens] 2179643 SBDC

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Triprolidine hydrochloride 0.625 MG/ML Oral Solution SCD · 1428927
Triprolidine hydrochloride 0.625 MG/ML SCDC · 1428926
Triprolidine Oral Solution SCDF · 376317
Triprolidine hydrochloride Oral Solution SCDFP · 2647555
Triprolidine Oral Liquid Product SCDG · 1159349
Triprolidine Oral Product SCDG · 1159350
Triprolidine hydrochloride Oral Liquid Product SCDGP · 2659962
Triprolidine hydrochloride Oral Product SCDGP · 2661554

Brand-Name Concepts

Triprolidine hydrochloride 0.625 MG/ML [Pediaclear Childrens] SBDC · 2179643
Triprolidine Oral Solution [Pediaclear Childrens] SBDF · 2179644
Triprolidine hydrochloride Oral Solution [Pediaclear Childrens] SBDFP · 2658680
Pediaclear Childrens Oral Liquid Product SBDG · 2179645
Pediaclear Childrens Oral Product SBDG · 2179646
Pediaclear Childrens BN · 2179642

📦 FDA Products & Package NDCs

1 product · 1 package NDC

1 package NDC map to RxCUI 2179647 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
58809-0651-50	50 mL in 1 BOTTLE, DROPPER (58809-651-50)	Childrens PediaClear PD	GM Pharmaceuticals, INC	2019-07-01

Observed labelers: GM Pharmaceuticals, INC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.